Host defence factors and prognosis in hairy cell leukemia

Evan M Hersh, Jorge Quesada, Michael J. Keating, Shelly Rasmussen, Samuel G. Murphy, Charles Gschwind, John Morgan

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Host defence parameters were characterized in 20 patients with hairy cell leukemia (HCL) and were related to hematological, clinical and prognostic variables. The diagnosis was confirmed by examination on the bone marrow by light and electron microscopy, and by staining for tartrate-resistant acid phosphatase. The major findings were markedly impaired delayed type hypersensitivity to recall antigens (mean skin test diameter in mm, HCL: 4.5, acute myelogenous leukemia: 17.4, normal: 14.8); low lymphocyte blastogenic responses to pokeweed mitogen (patients: 2.33 × 103 counts per min per culture, normals: 15.1) and concanavalin A (patients: 5.3 × 103 counts per min, normals: 31.9); low peripheral blood adherent monocytes (patients: 2.7 × 104/ml, normals: 14.8), low serum lysozyme (patients: 1.8 μg/ml, normals: 5.8) and virtually absent antibody-dependent cellular cytotoxicity ADCC to human erythrocytes (patients: 1.6% target cell lysis, normals: 8.7). In vitro addition of allogeneic monocytes restored the pokeweed mitogen and concanavalin A responses in 10 cases. There were significant negative correlations between the extent of bone marrow involvement with leukemia and several host defence parameters including ADCC to chicken erythrocytes (p = 0.002), delayed type hypersensitivity (p = 0.005), ADCC to the human leukemia CEM cell line (p = 0.3) and concanavalin A response (p = 0.03). Variables predicting prognosis included serum lysozyme (p = 0.008), ADCC to CEM (p = 0.009), delayed type hypersensitivity (p = 0.03), adherent monocytes (p = 0.04), concanavalin A response (p = 0.05) and platelet count (p = 0.05). These data indicate the important role of host defence parameters in the course of HCL and indicate the important role of host defence parameters in the course of HCL and indicate pathways for the study of the fundamental nature of the disease and its management.

Original languageEnglish (US)
Pages (from-to)625-637
Number of pages13
JournalLeukemia Research
Volume6
Issue number5
DOIs
StatePublished - 1982
Externally publishedYes

Fingerprint

Hairy Cell Leukemia
Antibody-Dependent Cell Cytotoxicity
Concanavalin A
Delayed Hypersensitivity
Monocytes
Pokeweed Mitogens
Muramidase
Leukemia
Erythrocytes
Bone Marrow Examination
Disease Management
Skin Tests
Serum
Platelet Count
Acute Myeloid Leukemia
Chickens
Electron Microscopy
Bone Marrow
Lymphocytes
Staining and Labeling

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Hersh, E. M., Quesada, J., Keating, M. J., Rasmussen, S., Murphy, S. G., Gschwind, C., & Morgan, J. (1982). Host defence factors and prognosis in hairy cell leukemia. Leukemia Research, 6(5), 625-637. https://doi.org/10.1016/0145-2126(82)90078-9

Host defence factors and prognosis in hairy cell leukemia. / Hersh, Evan M; Quesada, Jorge; Keating, Michael J.; Rasmussen, Shelly; Murphy, Samuel G.; Gschwind, Charles; Morgan, John.

In: Leukemia Research, Vol. 6, No. 5, 1982, p. 625-637.

Research output: Contribution to journalArticle

Hersh, EM, Quesada, J, Keating, MJ, Rasmussen, S, Murphy, SG, Gschwind, C & Morgan, J 1982, 'Host defence factors and prognosis in hairy cell leukemia', Leukemia Research, vol. 6, no. 5, pp. 625-637. https://doi.org/10.1016/0145-2126(82)90078-9
Hersh EM, Quesada J, Keating MJ, Rasmussen S, Murphy SG, Gschwind C et al. Host defence factors and prognosis in hairy cell leukemia. Leukemia Research. 1982;6(5):625-637. https://doi.org/10.1016/0145-2126(82)90078-9
Hersh, Evan M ; Quesada, Jorge ; Keating, Michael J. ; Rasmussen, Shelly ; Murphy, Samuel G. ; Gschwind, Charles ; Morgan, John. / Host defence factors and prognosis in hairy cell leukemia. In: Leukemia Research. 1982 ; Vol. 6, No. 5. pp. 625-637.
@article{98d678fcb4dd44fe86115d88257e93ae,
title = "Host defence factors and prognosis in hairy cell leukemia",
abstract = "Host defence parameters were characterized in 20 patients with hairy cell leukemia (HCL) and were related to hematological, clinical and prognostic variables. The diagnosis was confirmed by examination on the bone marrow by light and electron microscopy, and by staining for tartrate-resistant acid phosphatase. The major findings were markedly impaired delayed type hypersensitivity to recall antigens (mean skin test diameter in mm, HCL: 4.5, acute myelogenous leukemia: 17.4, normal: 14.8); low lymphocyte blastogenic responses to pokeweed mitogen (patients: 2.33 × 103 counts per min per culture, normals: 15.1) and concanavalin A (patients: 5.3 × 103 counts per min, normals: 31.9); low peripheral blood adherent monocytes (patients: 2.7 × 104/ml, normals: 14.8), low serum lysozyme (patients: 1.8 μg/ml, normals: 5.8) and virtually absent antibody-dependent cellular cytotoxicity ADCC to human erythrocytes (patients: 1.6{\%} target cell lysis, normals: 8.7). In vitro addition of allogeneic monocytes restored the pokeweed mitogen and concanavalin A responses in 10 cases. There were significant negative correlations between the extent of bone marrow involvement with leukemia and several host defence parameters including ADCC to chicken erythrocytes (p = 0.002), delayed type hypersensitivity (p = 0.005), ADCC to the human leukemia CEM cell line (p = 0.3) and concanavalin A response (p = 0.03). Variables predicting prognosis included serum lysozyme (p = 0.008), ADCC to CEM (p = 0.009), delayed type hypersensitivity (p = 0.03), adherent monocytes (p = 0.04), concanavalin A response (p = 0.05) and platelet count (p = 0.05). These data indicate the important role of host defence parameters in the course of HCL and indicate the important role of host defence parameters in the course of HCL and indicate pathways for the study of the fundamental nature of the disease and its management.",
author = "Hersh, {Evan M} and Jorge Quesada and Keating, {Michael J.} and Shelly Rasmussen and Murphy, {Samuel G.} and Charles Gschwind and John Morgan",
year = "1982",
doi = "10.1016/0145-2126(82)90078-9",
language = "English (US)",
volume = "6",
pages = "625--637",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",
number = "5",

}

TY - JOUR

T1 - Host defence factors and prognosis in hairy cell leukemia

AU - Hersh, Evan M

AU - Quesada, Jorge

AU - Keating, Michael J.

AU - Rasmussen, Shelly

AU - Murphy, Samuel G.

AU - Gschwind, Charles

AU - Morgan, John

PY - 1982

Y1 - 1982

N2 - Host defence parameters were characterized in 20 patients with hairy cell leukemia (HCL) and were related to hematological, clinical and prognostic variables. The diagnosis was confirmed by examination on the bone marrow by light and electron microscopy, and by staining for tartrate-resistant acid phosphatase. The major findings were markedly impaired delayed type hypersensitivity to recall antigens (mean skin test diameter in mm, HCL: 4.5, acute myelogenous leukemia: 17.4, normal: 14.8); low lymphocyte blastogenic responses to pokeweed mitogen (patients: 2.33 × 103 counts per min per culture, normals: 15.1) and concanavalin A (patients: 5.3 × 103 counts per min, normals: 31.9); low peripheral blood adherent monocytes (patients: 2.7 × 104/ml, normals: 14.8), low serum lysozyme (patients: 1.8 μg/ml, normals: 5.8) and virtually absent antibody-dependent cellular cytotoxicity ADCC to human erythrocytes (patients: 1.6% target cell lysis, normals: 8.7). In vitro addition of allogeneic monocytes restored the pokeweed mitogen and concanavalin A responses in 10 cases. There were significant negative correlations between the extent of bone marrow involvement with leukemia and several host defence parameters including ADCC to chicken erythrocytes (p = 0.002), delayed type hypersensitivity (p = 0.005), ADCC to the human leukemia CEM cell line (p = 0.3) and concanavalin A response (p = 0.03). Variables predicting prognosis included serum lysozyme (p = 0.008), ADCC to CEM (p = 0.009), delayed type hypersensitivity (p = 0.03), adherent monocytes (p = 0.04), concanavalin A response (p = 0.05) and platelet count (p = 0.05). These data indicate the important role of host defence parameters in the course of HCL and indicate the important role of host defence parameters in the course of HCL and indicate pathways for the study of the fundamental nature of the disease and its management.

AB - Host defence parameters were characterized in 20 patients with hairy cell leukemia (HCL) and were related to hematological, clinical and prognostic variables. The diagnosis was confirmed by examination on the bone marrow by light and electron microscopy, and by staining for tartrate-resistant acid phosphatase. The major findings were markedly impaired delayed type hypersensitivity to recall antigens (mean skin test diameter in mm, HCL: 4.5, acute myelogenous leukemia: 17.4, normal: 14.8); low lymphocyte blastogenic responses to pokeweed mitogen (patients: 2.33 × 103 counts per min per culture, normals: 15.1) and concanavalin A (patients: 5.3 × 103 counts per min, normals: 31.9); low peripheral blood adherent monocytes (patients: 2.7 × 104/ml, normals: 14.8), low serum lysozyme (patients: 1.8 μg/ml, normals: 5.8) and virtually absent antibody-dependent cellular cytotoxicity ADCC to human erythrocytes (patients: 1.6% target cell lysis, normals: 8.7). In vitro addition of allogeneic monocytes restored the pokeweed mitogen and concanavalin A responses in 10 cases. There were significant negative correlations between the extent of bone marrow involvement with leukemia and several host defence parameters including ADCC to chicken erythrocytes (p = 0.002), delayed type hypersensitivity (p = 0.005), ADCC to the human leukemia CEM cell line (p = 0.3) and concanavalin A response (p = 0.03). Variables predicting prognosis included serum lysozyme (p = 0.008), ADCC to CEM (p = 0.009), delayed type hypersensitivity (p = 0.03), adherent monocytes (p = 0.04), concanavalin A response (p = 0.05) and platelet count (p = 0.05). These data indicate the important role of host defence parameters in the course of HCL and indicate the important role of host defence parameters in the course of HCL and indicate pathways for the study of the fundamental nature of the disease and its management.

UR - http://www.scopus.com/inward/record.url?scp=0020354878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020354878&partnerID=8YFLogxK

U2 - 10.1016/0145-2126(82)90078-9

DO - 10.1016/0145-2126(82)90078-9

M3 - Article

C2 - 7154705

AN - SCOPUS:0020354878

VL - 6

SP - 625

EP - 637

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 5

ER -